Preoperative CRT can induce increased PD-L1 expression in rectal cancer (50–53), suggesting the potential benefits of combining radiotherapy or CRT with PD-1/PD-L1 blockade for an enhanced neoadjuvant strategy. The gene discussed is CD274; the disease is rectal cancer.